A Clinical Review of Biosimilars Approved in Oncology
{{output}}
Objective: To summarize and review the clinical data of Food and Drug Administration (FDA)-approved biosimilars for use in treatment of cancer and the current challenges health care institutions face when implementing a newly app... ...
